false
OasisLMS
ar,be,bn,zh-CN,zh-TW,en,fr,de,hi,id,it,ja,ko,pt,ru,es,sw,uz,vi
Login
Catalog
Nursing & Allied Health ECHO Case Presentations
Management of treatment induced menopausal symptom ...
Management of treatment induced menopausal symptoms
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The discussion centered on a 41-year-old ovarian cancer survivor who developed severe perimenopausal symptoms years after treatment. Ashley described how she assessed the patient’s history, symptoms, and risks in detail, then reviewed lifestyle measures, non-hormonal options, and the available guidance for hormone therapy after gynecologic cancer. Although the case was complex because of her prior endometrioid ovarian cancer and history of endometriosis, Ashley and her colleagues concluded that a cautious, low-dose estrogen approach with close follow-up was reasonable given the patient’s quality-of-life concerns and informed preferences.<br /><br />The group then broadened the conversation to gaps in menopause care for cancer survivors, including long waiting lists, inconsistent GP counseling, financial barriers, and poor access to pelvic floor, psychosexual, and fertility services. Several participants shared local initiatives such as nurse-led survivorship or pre-vivorship clinics, patient passports, and patient education resources. They also discussed the importance of genetic evaluation, individualized risk assessment, and involving patients directly in treatment decisions. Overall, the session emphasized that menopause care after cancer should be proactive, evidence-based, and integrated into survivorship care rather than delayed or outsourced.
Asset Subtitle
Recorded May 2026
Keywords
ovarian cancer survivor
perimenopausal symptoms
menopause care
hormone therapy
endometrioid ovarian cancer
endometriosis
survivorship care
non-hormonal options
patient-centered decision-making
×
Please select your language
1
English
11
Dutch
12
Russian